Select Page

South Delhi Pharma, New Delhi, India

ROZLYTREK (entrectinib) capsules, for oral use.

(4 customer reviews)

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

ROZLYTREK is a prescription medicine for non-small cell lung cancer (NSCLC) treatment.
INDICATIONS AND USAGE
ROZLYTREK is a kinase inhibitor indicated for the treatment of:
• Adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive. (1.1)
• Adult and pediatric patients 12 years of age and older with solid tumors
This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials.
DOSAGE FORMS & STRENGTHS
Capsules: 100 mg and 200 mg
Manufactured By: Genentech
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “ROZLYTREK (entrectinib) capsules” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Entrectinib, sold under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (TRK) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK).

It was approved for medical use in the United States in August 2019, in Australia in May 2020, and in the European Union in July 2020.

4 reviews for ROZLYTREK (entrectinib) capsules, for oral use.

  1. townhouses for sale in vaughan

    fascinate este conteúdo. Gostei bastante. Aproveitem e vejam este conteúdo. informações, novidades e muito mais. Não deixem de acessar para aprender mais. Obrigado a todos e até a próxima. 🙂

    https://www.skyhub.ca/on/vaughan/townhomes-for-sale

  2. oogspoeling

    It¦s really a cool and helpful piece of information. I¦m happy that you shared this helpful information with us. Please keep us informed like this. Thank you for sharing.

    https://www.ehbo-centrum.nl/oogspoeling-c-504.html

  3. emultetly

    2 is a safe treatment for patients thought to have an anal fissure and spastic sphincter, even when those findings cannot be confirmed on physical examination clomid without prescriptions mexico Move forward

  4. russian school of math

    Appreciating the persistence you put into your site and detailed information you provide. It’s awesome to come across a blog every once in a while that isn’t the same unwanted rehashed material. Fantastic read! I’ve saved your site and I’m including your RSS feeds to my Google account.

    https://russianmathtutors.com

Add a review

Your email address will not be published. Required fields are marked *